Nathan Singh, MD, MS

Nathan Singh, MD, MS

Medical Oncologist

Primary Academic Title

Assistant Professor of Medicine, Division of Oncology, Washington University School of Medicine

Clinical Expertise

Leukemia, hematopoietic cell transplantation

Research Interest

Understanding how blood cancers resist cellular immunotherapy by causing dysfunctional activity of adoptively transferred T cells

Education

  • 2013: MD, University of Pennsylvania, Philadelphia
  • 2013: MS, translational research, University of Pennsylvania

Training

  • 2014 - 2016: Resident, internal medicine, Hospital of the University of Pennsylvania, Philadelphia
  • 2016 - 2019: Fellow, hematology and oncology, University of Pennsylvania Health System, Philadelphia

Board Certification

  • 2017: American Board of Internal Medicine

Selected Research Publications

Costimulatory domains direct distinct fates of CAR-driven T-cell dysfunction.
  • Selli ME, Landmann JH, Terekhova M, [...] Singh N
  • Blood 2023
Antigen glycosylation regulates efficacy of CAR T cells targeting CD19.
  • Heard A, Landmann JH, Hansen AR, [...] Singh N
  • Nat Commun 2022
Modified T cells as therapeutic agents.
  • Singh N
  • Hematology Am Soc Hematol Educ Program 2021
Advances in CAR design.
  • Heard A, Chang J, Warrington JM, Singh N
  • Best Pract Res Clin Haematol 2021